CORCEPT THERAPEUTICS INC Increase (Decrease) in Income Taxes Payable
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Income Taxes Payable of $48.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2025-11-04
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$1.54M, a 269.78% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for the quarter ending 2024-09-30 was $910.00K, a 75.68% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for the quarter ending 2023-09-30 was $518.00K, a 71.88% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for the quarter ending 2022-09-30 was $1.84M, a 18320.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for fiscal 2018 was $239.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for fiscal 2017 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in income taxes payable for fiscal 2016 was $0.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $48.00K 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $1.59M 10-Q · filed 2025-07-31 | |||
| 2024-09-30 | $910.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.54M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $1.63M 10-Q · filed 2025-07-31 | |||
| 2023-09-30 | $518.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.37M 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $855.00K 10-Q · filed 2024-07-29 | |||
| 2022-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.41M 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $4.57M 10-Q · filed 2023-08-02 | |||
| 2021-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-04 | |||
| 2018-12-31 | $239.00K 10-K · filed 2019-02-26 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |